FDA Expects Wide Range Of Peripheral Drug-Eluting Stent Applications

FDA may consider granting a broad indication to leg stents based on data from the "worst" part of the leg vasculature, according to CDRH Peripheral Vascular Devices Branch Chief David Buckles, PhD

More from Archive

More from Medtech Insight